Alida Biosciences
San Diego
About Alida Biosciences
Alida Biosciences is a biotechnology company developing next-generation epigenetic and epitranscriptomic sequencing technologies that uncover regulatory information beyond DNA sequence alone. By enabling high-resolution, quantitative analysis of RNA modifications, Alida’s EpiPlex platform and EpiScout software reveals previously inaccessible biology that drives disease onset, progression, and therapeutic response. The company’s tools support advanced biomarker discovery and functional genomics across oncology, autoimmune, and neurodegenerative diseases, serving academic researchers, biopharma, and diagnostic partners seeking deeper insight into gene regulation for precision medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Nov 2025)
- Website: alidabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Software
Social Profiles
Canonical: https://fsome.com/organization/alida-biosciences-33241 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.